Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cathepsin D anticorps

CTSD Reactivité: Humain WB, IHC, IP, IF Hôte: Souris Monoclonal 49-Cathepsin D unconjugated
N° du produit ABIN968184
  • Antigène Voir toutes Cathepsin D (CTSD) Anticorps
    Cathepsin D (CTSD)
    Reactivité
    • 103
    • 48
    • 27
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 92
    • 22
    • 3
    • 1
    Souris
    Clonalité
    • 88
    • 28
    Monoclonal
    Conjugué
    • 72
    • 10
    • 6
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Cathepsin D est non-conjugé
    Application
    • 87
    • 36
    • 27
    • 19
    • 14
    • 13
    • 13
    • 11
    • 10
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (IF)
    Attributs du produit
    1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
    2. Please refer to us for technical protocols.
    3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
    4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
    Purification
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogène
    Human Cathepsin D
    Clone
    49-Cathepsin D
    Isotype
    IgG2a
    Top Product
    Discover our top product CTSD Anticorps primaire
  • Commentaires

    Related Products: ABIN967389, ABIN968587

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    250 μg/mL
    Buffer
    Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store undiluted at -20°C.
  • Westley, May: "Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells." dans: Nucleic acids research, Vol. 15, Issue 9, pp. 3773-86, (1987) (PubMed).

    Faust, Kornfeld, Chirgwin: "Cloning and sequence analysis of cDNA for human cathepsin D." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 82, Issue 15, pp. 4910-4, (1985) (PubMed).

    Erickson, Conner, Blobel: "Biosynthesis of a lysosomal enzyme. Partial structure of two transient and functionally distinct NH2-terminal sequences in cathepsin D." dans: The Journal of biological chemistry, Vol. 256, Issue 21, pp. 11224-31, (1981) (PubMed).

    Kageyama, Takahashi: "A cathepsin D-like acid proteinase from human gastric mucosa. Purification and characterization." dans: Journal of biochemistry, Vol. 87, Issue 3, pp. 725-35, (1980) (PubMed).

  • Antigène
    Cathepsin D (CTSD)
    Autre désignation
    Cathepsin D (CTSD Produits)
    Synonymes
    anticorps catD, anticorps fb93e11, anticorps fj17b09, anticorps wu:fb93e11, anticorps wu:fj17b09, anticorps LOC398557, anticorps Cathd, anticorps CatD, anticorps LOC100136761, anticorps CTSD, anticorps DKFZp469J0315, anticorps DDBDRAFT_0205785, anticorps DDBDRAFT_0215012, anticorps DDB_0205785, anticorps DDB_0215012, anticorps CLN10, anticorps CPSD, anticorps CD, anticorps cathepsin D, anticorps cathepsin D S homeolog, anticorps lysosomal aspartic protease, anticorps cathepsin D-like, anticorps ctsd, anticorps LOC398557, anticorps ctsd.S, anticorps CatD, anticorps LOC5567565, anticorps LOC100136761, anticorps CTSD, anticorps Cathd, anticorps ctsD, anticorps catd, anticorps Ctsd, anticorps LOC443060
    Sujet
    Cathepsin D, an enzyme that degrades proteins, was originally cloned during the search of estrogen responsive genes in MCF-7 cells. Cathepsin D is synthesized as the 43kDa preprocathepsin D that is cleaved to form a 46kDa glycosylated procathepsin D. Procathepsin is then processed into a 44kDa active Cathepsin D. The active and mature forms undergo a further cleavage that yields 28kDa and 15kDa (heavy and light chains, respectively) fragments in SDS-PAGE. The heavy and light chains of Cathepsin D are released into the extracellular medium. The maturation process of Cathepsin D occurs through the transit from the endoplasmic reticulum, Golgi apparatus, and to the lysosomes. Estrogens stimulate cell proliferation in a number of tumor cell lines and anti-estrogen therapy is often used in the treatment of breast cancer patients. Therefore, Cathepsin D, which is estrogen inducible, may have a role during the pathogenesis of breast tumors. Additionally, several other roles have been proposed for this enzyme, such as tissue remodeling, tumor invasion, and embryo implantation.
    Poids moléculaire
    43/28 kDa
    Pathways
    Peptide Hormone Metabolism
Vous êtes ici:
Support technique